Aditxt Inc XNAS: ADTX

Aditxt Inc Live Share Price Today, Share Analysis and Chart

4.87 0.35 (7.74%)

97.77% Fall from 52W High

88,455 XNAS Volume

XNAS 02 Apr, 2025 11:59 AM (EDT)

Aditxt Inc Key Metrics

Default
All financials are in USD Million and price data in USD
VIEW MORE
Not Eligible
-
Expensive Valuation
18.5 / 100
Technically Neutral
42.7 / 100

Aditxt Inc Live Price Chart

Switch to TradingView
Fetching data ...

Aditxt Inc Stock Analysis

Aditxt Inc stock analysis with key metrics, changes, and trends.

Aditxt Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$0.65 M30.9%negative

Annual Revenue fell 30.9%, in the last year to $0.65 M. Its sector's average revenue growth for the last fiscal year was 7.47%.

Annual Net Profit$32.38 M17.11%negative

Annual Net Profit fell 17.11% in the last year to $32.38 M. Its sector's average net profit growth for the last fiscal year was -32.28%.

Price to Earning Ratio-0.12-negative

Price to Earning Ratio is -0.12, which is negative.

Stock Price$4.87-96.17%negative

Stock Price fell 96.17% and underperformed its sector by 100.66% in the past year.

Quarterly Revenue$0.01 M94.5%negative

Quarterly Revenue fell 94.5% YoY to $0.01 M. Its sector's average revenue growth YoY for the quarter was 5.94%.

Quarterly Net profit$6.94 M28.79%positive

Quarterly Net profit rose 28.79% YoY to $6.94 M. Its sector's average net profit growth YoY for the quarter was -47.34%.

Debt to Equity Ratio1.13-negative

Debt to Equity Ratio of 1.13 is higher than 1. This implies that company assets are financed through debt.

Return on Equity(ROE)-307.59 %-307.59%negative

Return on Equity(ROE) for the last financial year was -307.59%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding2.29 %0%negative

Mutual Fund Holding decreased by 0% in the last quarter to 2.29.

Interest Coverage Ratio-4.07-negative

Interest Coverage Ratio is -4.07, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding0.03 %0%neutral

Institutional Holding remained the same in the last quarter at 0.03%.

VIEW LESS


Loading data..

Aditxt Inc - Company Profile

What does Aditxt Inc do?

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.

Aditxt Inc Management structure

All Gross Remunerations are in USD
Mr. Matthew Shatzkes
Chief Legal Officer and General Counsel
1.12 M
2023
Gross Remuneration
Year
Mr. Amro A. Albanna
Chairman of the Board and Chief Executive Officer
519.23 K
2023
Gross Remuneration
Year
Ms. Corinne Pankovcin
Chief Mergers and Acquisitions Officer
390.33 K
2023
Gross Remuneration
Year
Mr. Thomas J. Farley
Chief Financial Officer and Principal Accounting Officer
381.45 K
2023
Gross Remuneration
Year
Dr. Shahrokh Shabahang, D.D.S.,M.S.,PhD
Director and Chief Innovation Officer
358.84 K
2023
Gross Remuneration
Year
Ms. Rowena Albanna
Chief Operating Officer
-
2023
Gross Remuneration
Year

Aditxt Inc Board of directors

All Gross Remunerations are in USD
Ms. Sylvia Hermina
Director
-
2024
Gross Remuneration
Year

Aditxt Inc FAQ

How is Aditxt Inc today?
Aditxt Inc today is trading in the green, and is up by 7.74% at 4.87.
Aditxt Inc is currently trading up 7.74% on an intraday basis. In the past week the stock fell -30.03%. stock has been up 2463.16% in the past quarter and fell -96.17% in the past year. You can view this in the overview section.